Browsing: KRAS

A look back at patients receiving radiosurgery for non-small cell lung cancer brain metastases reports KRAS mutation status is not…

KRAS G12D-mutations–common drivers of pancreatic cancer (~40%) and also present in non-small cell lung cancer (5%)–can now be targeted with…

In this retrospective study, local control with SRS for brain metastases from KRAS-mutated lung cancer was 89.9% at 12 months…

Notably upwards of 90% of pancreatic adenocarcinomas harboring KRAS-mutations, a database study reveals allele-specific KRAS-mutations may pan out to be…

A SEER analysis reveals a significantly longer cancer-specific survival with KRAS-wildtype colorectal cancer than with KRAS-variant, a discrepancy that was…